Signal Longevity investment up 220% to $8.5 billion with animal lifespans extended 30-74%

Summary

This signal captures rising money and early results in research aimed at extending human life. Investment in longevity research reached US$8.5b in 2024, a 220% jump from the year before. EY links this acceleration to AI-driven drug discovery. Compounds identified by AI have lengthened the lifespans of animals by 30% to 74%, and trials in humans are now in progress. EY argues that longer lives could fundamentally change how organizations plan their workforces. It also raises difficult questions about pensions, healthcare costs and fairness between generations.